²é¿´ÍêÕû°æ±¾: [-- µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© --]

¿¼²©ÂÛ̳ -> µÚËľüÒ½´óѧ -> µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© [´òÓ¡±¾Ò³] µÇ¼ -> ×¢²á -> »Ø¸´Ö÷Ìâ -> ·¢±íÖ÷Ìâ

leagecn 2007-01-20 18:24

µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£©

µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© w_qX~d/  
VJbsM1y M  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© K93L-K^J  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 0RFBun{  
1.Co-stimulators (or co-stimulating molecules) D8X~qt/  
2.NK-kB USd7g Oq(  
3.Immunoglobulin superfamily jKr\mb  
4.antigen-presenting cell (APC) pLj[b4p9  
5.death domain &~=FX e0S  
6.CCR and CXCR tVQq,_9C  
7.Lectin (or mitogen) #No3}O;"g  
8.Clusters of differentiation, CD) .fFXH  
9.B7 family y'L7o V?L9  
10.Cytotoxic T lymphocyte, CTL) VO JA}$  
11.IL-15 and IL-15 receptor (IL-15R) |P0!dt7sQ  
12.MHC restriction AjVX  
13.Affinity-chromatography |xawguJ  
14.Cyctosprin A, CsA OEw#;l4 C  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) y>^FKN/  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© gFpub_  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 7F2 WmMS  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ CY~ S{w  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹Ô­µÄÌص㡣 "7q!u,u  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© E/V_gci  
ÃâÒßѧרҵ£º po\(O8#5U  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ {8I,uQO  
Ïû»¯ÄÚ¿Æ£º A!cY!aQ  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£  .0YcB  
ѪҺ²¡Ñ§×¨Òµ£º 3{)!T;Wd  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿


²é¿´ÍêÕû°æ±¾: [-- µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© --] [-- top --]


Powered by freekaobo v7.5 SP3 Code ©2003-2010 PHPWind
Gzip enabled

You can contact us